Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lyme Disease | 47 | 2024 | 630 | 11.970 |
Why?
|
Meningitis, Bacterial | 35 | 2024 | 225 | 7.220 |
Why?
|
Head Injuries, Closed | 7 | 2019 | 133 | 3.050 |
Why?
|
Spinal Puncture | 15 | 2020 | 286 | 2.650 |
Why?
|
Serologic Tests | 9 | 2024 | 383 | 2.550 |
Why?
|
Emergency Service, Hospital | 59 | 2024 | 7955 | 2.400 |
Why?
|
Diabetic Ketoacidosis | 13 | 2023 | 255 | 2.400 |
Why?
|
Fever | 22 | 2024 | 1620 | 2.350 |
Why?
|
Immunoenzyme Techniques | 7 | 2021 | 1705 | 2.200 |
Why?
|
Bacterial Infections | 11 | 2024 | 1397 | 2.080 |
Why?
|
Meningitis, Aseptic | 9 | 2013 | 59 | 2.050 |
Why?
|
Cerebrospinal Fluid Shunts | 5 | 2018 | 197 | 1.900 |
Why?
|
Bacteremia | 14 | 2024 | 985 | 1.720 |
Why?
|
Meningitis | 7 | 2023 | 219 | 1.610 |
Why?
|
Decision Support Techniques | 13 | 2019 | 2006 | 1.530 |
Why?
|
Meningitis, Viral | 6 | 2017 | 50 | 1.530 |
Why?
|
Cerebrospinal Fluid | 14 | 2021 | 545 | 1.430 |
Why?
|
Arthritis, Infectious | 7 | 2024 | 347 | 1.390 |
Why?
|
Borrelia burgdorferi | 8 | 2024 | 183 | 1.380 |
Why?
|
Lyme Neuroborreliosis | 5 | 2020 | 50 | 1.380 |
Why?
|
Child | 119 | 2024 | 80891 | 1.340 |
Why?
|
Wounds, Nonpenetrating | 7 | 2015 | 809 | 1.280 |
Why?
|
Infant | 93 | 2024 | 36510 | 1.260 |
Why?
|
Endemic Diseases | 6 | 2024 | 190 | 1.250 |
Why?
|
Leukocyte Count | 14 | 2024 | 1605 | 1.230 |
Why?
|
Polymerase Chain Reaction | 11 | 2019 | 6085 | 1.200 |
Why?
|
Facial Paralysis | 4 | 2017 | 346 | 1.150 |
Why?
|
Skull Fractures | 4 | 2020 | 203 | 1.130 |
Why?
|
Synovial Fluid | 4 | 2024 | 393 | 1.130 |
Why?
|
Leukocytosis | 10 | 2021 | 250 | 1.130 |
Why?
|
Fluid Therapy | 9 | 2023 | 585 | 1.110 |
Why?
|
Immunoblotting | 3 | 2019 | 1647 | 1.070 |
Why?
|
Erythema Chronicum Migrans | 2 | 2023 | 48 | 1.050 |
Why?
|
Sensitivity and Specificity | 33 | 2024 | 14737 | 1.050 |
Why?
|
Enterovirus | 4 | 2017 | 69 | 0.990 |
Why?
|
Child, Preschool | 63 | 2024 | 42650 | 0.970 |
Why?
|
Enterovirus Infections | 5 | 2017 | 74 | 0.960 |
Why?
|
Brain Injuries | 7 | 2022 | 2059 | 0.940 |
Why?
|
Anti-Bacterial Agents | 19 | 2024 | 7463 | 0.940 |
Why?
|
Ceftriaxone | 4 | 2023 | 175 | 0.910 |
Why?
|
Antibodies, Bacterial | 8 | 2024 | 1478 | 0.900 |
Why?
|
Central Nervous System Infections | 1 | 2024 | 61 | 0.870 |
Why?
|
Craniocerebral Trauma | 6 | 2020 | 495 | 0.850 |
Why?
|
Immunoglobulin M | 6 | 2024 | 1528 | 0.830 |
Why?
|
Tomography, X-Ray Computed | 18 | 2020 | 20765 | 0.820 |
Why?
|
Cerebrospinal Fluid Proteins | 5 | 2018 | 71 | 0.810 |
Why?
|
Adolescent | 72 | 2024 | 89184 | 0.770 |
Why?
|
Ondansetron | 2 | 2020 | 95 | 0.760 |
Why?
|
Bicycling | 2 | 2014 | 177 | 0.760 |
Why?
|
Accidents, Traffic | 4 | 2015 | 819 | 0.720 |
Why?
|
Ixodes | 1 | 2020 | 40 | 0.720 |
Why?
|
Antiemetics | 2 | 2020 | 188 | 0.710 |
Why?
|
Doxycycline | 2 | 2023 | 348 | 0.700 |
Why?
|
Herpes Simplex | 6 | 2022 | 470 | 0.690 |
Why?
|
Clinical Enzyme Tests | 1 | 2019 | 114 | 0.680 |
Why?
|
Retrospective Studies | 78 | 2024 | 81801 | 0.660 |
Why?
|
Complement C6 | 1 | 2018 | 14 | 0.650 |
Why?
|
Pediatrics | 10 | 2024 | 3624 | 0.640 |
Why?
|
Otitis Media | 2 | 2020 | 288 | 0.640 |
Why?
|
Infant, Newborn | 47 | 2022 | 26411 | 0.640 |
Why?
|
Skull | 2 | 2015 | 831 | 0.630 |
Why?
|
Humans | 192 | 2024 | 768393 | 0.620 |
Why?
|
Diagnosis, Differential | 19 | 2022 | 13020 | 0.600 |
Why?
|
Herpes Zoster Oticus | 1 | 2017 | 7 | 0.600 |
Why?
|
Glasgow Coma Scale | 7 | 2021 | 580 | 0.590 |
Why?
|
Hospitals, Pediatric | 11 | 2019 | 1876 | 0.590 |
Why?
|
Urinary Tract Infections | 7 | 2022 | 806 | 0.580 |
Why?
|
Hospitalization | 14 | 2021 | 10844 | 0.580 |
Why?
|
Multi-Institutional Systems | 1 | 2017 | 43 | 0.570 |
Why?
|
Emergency Medicine | 4 | 2021 | 1222 | 0.570 |
Why?
|
Facial Nerve Injuries | 1 | 2017 | 64 | 0.560 |
Why?
|
Cross-Sectional Studies | 37 | 2023 | 26375 | 0.550 |
Why?
|
Male | 112 | 2024 | 364902 | 0.540 |
Why?
|
C-Reactive Protein | 3 | 2019 | 3857 | 0.540 |
Why?
|
Bibliometrics | 1 | 2020 | 355 | 0.540 |
Why?
|
Publishing | 2 | 2020 | 836 | 0.530 |
Why?
|
Female | 114 | 2024 | 397089 | 0.530 |
Why?
|
Simplexvirus | 4 | 2022 | 805 | 0.510 |
Why?
|
Knee Joint | 3 | 2022 | 1686 | 0.500 |
Why?
|
Bacteria | 6 | 2022 | 2221 | 0.490 |
Why?
|
Emergency Treatment | 4 | 2021 | 496 | 0.480 |
Why?
|
Accidental Falls | 2 | 2014 | 1080 | 0.480 |
Why?
|
Prospective Studies | 27 | 2023 | 54920 | 0.470 |
Why?
|
Hydrocephalus | 3 | 2018 | 770 | 0.470 |
Why?
|
Rheumatology | 5 | 2021 | 619 | 0.460 |
Why?
|
Nursing Diagnosis | 1 | 2013 | 16 | 0.450 |
Why?
|
Physician-Nurse Relations | 1 | 2013 | 20 | 0.440 |
Why?
|
Periodicals as Topic | 3 | 2024 | 1469 | 0.420 |
Why?
|
Advisory Committees | 1 | 2017 | 797 | 0.410 |
Why?
|
Mental Recall | 1 | 2019 | 1226 | 0.410 |
Why?
|
Quality Improvement | 3 | 2017 | 3858 | 0.400 |
Why?
|
Clinical Medicine | 1 | 2013 | 145 | 0.390 |
Why?
|
Cervical Vertebrae | 4 | 2013 | 982 | 0.390 |
Why?
|
Trauma Severity Indices | 5 | 2015 | 479 | 0.390 |
Why?
|
Spinal Injuries | 2 | 2012 | 300 | 0.390 |
Why?
|
Informed Consent | 1 | 2018 | 1010 | 0.380 |
Why?
|
Hip Joint | 1 | 2018 | 1018 | 0.370 |
Why?
|
Neutrophils | 5 | 2024 | 3785 | 0.370 |
Why?
|
Cohort Studies | 25 | 2023 | 41795 | 0.340 |
Why?
|
Arthropod Vectors | 1 | 2008 | 6 | 0.320 |
Why?
|
Research | 1 | 2017 | 1981 | 0.310 |
Why?
|
Emergencies | 3 | 2021 | 1219 | 0.310 |
Why?
|
Tularemia | 1 | 2008 | 40 | 0.310 |
Why?
|
Glucose | 5 | 2023 | 4352 | 0.310 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3813 | 0.300 |
Why?
|
Blood Cell Count | 4 | 2019 | 402 | 0.300 |
Why?
|
Tick-Borne Diseases | 1 | 2008 | 37 | 0.300 |
Why?
|
Parents | 3 | 2019 | 3596 | 0.300 |
Why?
|
Blood Sedimentation | 2 | 2019 | 235 | 0.300 |
Why?
|
Francisella tularensis | 1 | 2008 | 60 | 0.300 |
Why?
|
Child Abuse | 1 | 2017 | 1096 | 0.300 |
Why?
|
Clinical Laboratory Techniques | 1 | 2013 | 749 | 0.300 |
Why?
|
Emergency Medical Services | 4 | 2021 | 1946 | 0.290 |
Why?
|
Pneumococcal Vaccines | 2 | 2008 | 414 | 0.280 |
Why?
|
False Negative Reactions | 2 | 2020 | 575 | 0.280 |
Why?
|
Predictive Value of Tests | 14 | 2021 | 15455 | 0.280 |
Why?
|
Lyme Disease Vaccines | 1 | 2006 | 18 | 0.270 |
Why?
|
Bacterial Vaccines | 1 | 2009 | 400 | 0.270 |
Why?
|
Insulin | 1 | 2021 | 6607 | 0.270 |
Why?
|
Heart Ventricles | 1 | 2018 | 3838 | 0.260 |
Why?
|
Vomiting | 2 | 2020 | 655 | 0.260 |
Why?
|
Immunoglobulin G | 4 | 2024 | 4570 | 0.260 |
Why?
|
Boston | 8 | 2019 | 9371 | 0.260 |
Why?
|
Status Epilepticus | 3 | 2017 | 463 | 0.260 |
Why?
|
Central Nervous System Viral Diseases | 2 | 2018 | 40 | 0.260 |
Why?
|
Erythrocytes | 3 | 2017 | 2421 | 0.260 |
Why?
|
Thrombocytosis | 1 | 2006 | 88 | 0.260 |
Why?
|
Guideline Adherence | 2 | 2015 | 2240 | 0.250 |
Why?
|
United States | 31 | 2024 | 73150 | 0.250 |
Why?
|
Skin Pigmentation | 1 | 2007 | 278 | 0.250 |
Why?
|
Clinical Competence | 2 | 2018 | 4848 | 0.240 |
Why?
|
Young Adult | 21 | 2024 | 60049 | 0.240 |
Why?
|
Equipment Failure | 2 | 2018 | 585 | 0.230 |
Why?
|
Neurology | 3 | 2021 | 786 | 0.230 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5891 | 0.230 |
Why?
|
Health Services Research | 3 | 2021 | 1817 | 0.230 |
Why?
|
Labor, Obstetric | 1 | 2007 | 323 | 0.230 |
Why?
|
Risk Factors | 23 | 2024 | 74962 | 0.230 |
Why?
|
False Positive Reactions | 2 | 2016 | 962 | 0.220 |
Why?
|
Length of Stay | 6 | 2019 | 6519 | 0.220 |
Why?
|
Pneumococcal Infections | 1 | 2008 | 529 | 0.220 |
Why?
|
Severity of Illness Index | 7 | 2020 | 15939 | 0.220 |
Why?
|
Myocarditis | 2 | 2021 | 803 | 0.210 |
Why?
|
Urinalysis | 6 | 2022 | 369 | 0.210 |
Why?
|
Family | 2 | 2019 | 3208 | 0.210 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2023 | 3440 | 0.210 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2024 | 239 | 0.210 |
Why?
|
Pyuria | 1 | 2022 | 30 | 0.210 |
Why?
|
Pyomyositis | 1 | 2022 | 10 | 0.200 |
Why?
|
Communicable Diseases | 2 | 2021 | 873 | 0.200 |
Why?
|
Infusions, Intravenous | 3 | 2023 | 2226 | 0.200 |
Why?
|
Reproducibility of Results | 12 | 2020 | 20224 | 0.200 |
Why?
|
Erythrocyte Count | 2 | 2020 | 157 | 0.190 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2006 | 372 | 0.190 |
Why?
|
ROC Curve | 6 | 2024 | 3623 | 0.190 |
Why?
|
Pneumonia | 2 | 2023 | 2163 | 0.190 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2006 | 539 | 0.190 |
Why?
|
Practice Guidelines as Topic | 5 | 2020 | 7453 | 0.180 |
Why?
|
Radiography | 1 | 2012 | 6993 | 0.180 |
Why?
|
Oxadiazoles | 1 | 2001 | 94 | 0.180 |
Why?
|
Rotavirus Infections | 1 | 2002 | 85 | 0.180 |
Why?
|
Rotavirus | 1 | 2002 | 110 | 0.180 |
Why?
|
Delivery, Obstetric | 1 | 2007 | 952 | 0.170 |
Why?
|
Societies, Medical | 3 | 2020 | 3960 | 0.170 |
Why?
|
Lymphadenitis | 1 | 2020 | 99 | 0.170 |
Why?
|
Risk Assessment | 9 | 2021 | 24318 | 0.170 |
Why?
|
Brain Concussion | 3 | 2017 | 1433 | 0.170 |
Why?
|
Cerebellar Diseases | 1 | 2002 | 221 | 0.170 |
Why?
|
Biomedical Research | 3 | 2020 | 3464 | 0.160 |
Why?
|
Congresses as Topic | 2 | 2024 | 810 | 0.160 |
Why?
|
Brain Edema | 2 | 2021 | 607 | 0.160 |
Why?
|
Acidosis | 1 | 2021 | 271 | 0.160 |
Why?
|
Sodium | 2 | 2021 | 1594 | 0.160 |
Why?
|
Acute Kidney Injury | 2 | 2022 | 1943 | 0.160 |
Why?
|
Algorithms | 6 | 2024 | 14154 | 0.160 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2007 | 1039 | 0.160 |
Why?
|
Blood Glucose | 2 | 2023 | 6430 | 0.160 |
Why?
|
Borrelia | 1 | 2019 | 66 | 0.160 |
Why?
|
Delphi Technique | 2 | 2020 | 888 | 0.160 |
Why?
|
Bacteriuria | 1 | 2019 | 102 | 0.160 |
Why?
|
Medical Errors | 1 | 2007 | 1263 | 0.150 |
Why?
|
Rehydration Solutions | 1 | 2018 | 43 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2022 | 408 | 0.150 |
Why?
|
Follow-Up Studies | 11 | 2018 | 39407 | 0.150 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2019 | 113 | 0.150 |
Why?
|
Pakistan | 1 | 2018 | 298 | 0.150 |
Why?
|
Judgment | 1 | 2019 | 272 | 0.140 |
Why?
|
Ticks | 2 | 2008 | 71 | 0.140 |
Why?
|
Scalp | 1 | 2020 | 391 | 0.140 |
Why?
|
Decision Support Systems, Clinical | 2 | 2019 | 1177 | 0.140 |
Why?
|
Statistics as Topic | 2 | 2015 | 2363 | 0.140 |
Why?
|
Multivariate Analysis | 8 | 2012 | 12092 | 0.140 |
Why?
|
Financing, Organized | 1 | 2019 | 203 | 0.140 |
Why?
|
Encephalitis, Viral | 1 | 2017 | 59 | 0.140 |
Why?
|
Incidence | 9 | 2018 | 21544 | 0.140 |
Why?
|
Peer Review | 1 | 2019 | 219 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 2 | 2016 | 790 | 0.140 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2412 | 0.140 |
Why?
|
Age Factors | 9 | 2021 | 18471 | 0.140 |
Why?
|
Hypoglycemia | 2 | 2021 | 894 | 0.140 |
Why?
|
Antiviral Agents | 2 | 2017 | 3064 | 0.140 |
Why?
|
Seizures | 3 | 2021 | 3000 | 0.140 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3707 | 0.130 |
Why?
|
Prevalence | 4 | 2022 | 15872 | 0.130 |
Why?
|
Musculoskeletal Diseases | 1 | 2022 | 601 | 0.130 |
Why?
|
Authorship | 1 | 2019 | 289 | 0.130 |
Why?
|
International Cooperation | 2 | 2021 | 1438 | 0.130 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 589 | 0.130 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 238 | 0.130 |
Why?
|
Trauma Centers | 2 | 2011 | 947 | 0.130 |
Why?
|
Hematoma | 1 | 2020 | 768 | 0.130 |
Why?
|
Seat Belts | 1 | 2015 | 60 | 0.120 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2015 | 67 | 0.120 |
Why?
|
Environment | 1 | 2021 | 1124 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 784 | 0.120 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2017 | 342 | 0.120 |
Why?
|
International Classification of Diseases | 3 | 2015 | 924 | 0.120 |
Why?
|
Interinstitutional Relations | 1 | 2016 | 236 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 4 | 2015 | 36849 | 0.120 |
Why?
|
Editorial Policies | 1 | 2019 | 459 | 0.120 |
Why?
|
Nurse Practitioners | 2 | 2018 | 271 | 0.120 |
Why?
|
Time Factors | 9 | 2020 | 40272 | 0.120 |
Why?
|
Abscess | 1 | 2018 | 606 | 0.110 |
Why?
|
Vulnerable Populations | 1 | 2019 | 718 | 0.110 |
Why?
|
Education, Nursing, Diploma Programs | 1 | 2013 | 11 | 0.110 |
Why?
|
Cell Count | 1 | 2018 | 1833 | 0.110 |
Why?
|
Confidence Intervals | 4 | 2012 | 2931 | 0.110 |
Why?
|
Ambulatory Care | 2 | 2015 | 2784 | 0.110 |
Why?
|
Physical Examination | 1 | 2020 | 1262 | 0.110 |
Why?
|
Acute Disease | 3 | 2019 | 7242 | 0.110 |
Why?
|
Head | 1 | 2019 | 927 | 0.110 |
Why?
|
Databases, Factual | 5 | 2019 | 8075 | 0.110 |
Why?
|
Child Restraint Systems | 1 | 2012 | 20 | 0.100 |
Why?
|
Comparative Effectiveness Research | 1 | 2018 | 713 | 0.100 |
Why?
|
Ataxia | 1 | 2014 | 307 | 0.100 |
Why?
|
Parenting | 1 | 2018 | 708 | 0.100 |
Why?
|
Case-Control Studies | 5 | 2022 | 22296 | 0.100 |
Why?
|
Drainage | 1 | 2018 | 1184 | 0.100 |
Why?
|
Blood Proteins | 1 | 2017 | 1186 | 0.100 |
Why?
|
Cognition | 3 | 2023 | 7075 | 0.100 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 162 | 0.100 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 811 | 0.100 |
Why?
|
Hospital Costs | 2 | 2013 | 959 | 0.100 |
Why?
|
Diarrhea | 1 | 2018 | 1320 | 0.100 |
Why?
|
Absenteeism | 1 | 2013 | 247 | 0.100 |
Why?
|
Italy | 1 | 2014 | 854 | 0.100 |
Why?
|
Pandemics | 2 | 2023 | 8753 | 0.100 |
Why?
|
Poisson Distribution | 1 | 2013 | 509 | 0.100 |
Why?
|
Gentian Violet | 2 | 2019 | 25 | 0.090 |
Why?
|
Hypertension | 2 | 2023 | 8615 | 0.090 |
Why?
|
Statistics, Nonparametric | 3 | 2016 | 2862 | 0.090 |
Why?
|
Phenazines | 2 | 2019 | 53 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2001 | 1762 | 0.090 |
Why?
|
Cranial Nerve Diseases | 1 | 2011 | 111 | 0.090 |
Why?
|
DNA, Viral | 1 | 2018 | 2205 | 0.090 |
Why?
|
Caustics | 1 | 2001 | 33 | 0.090 |
Why?
|
Program Evaluation | 2 | 2017 | 2505 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1998 | 0.090 |
Why?
|
Hair Preparations | 1 | 2001 | 32 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1280 | 0.090 |
Why?
|
Health Education | 1 | 2017 | 1057 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1448 | 0.090 |
Why?
|
Brain | 2 | 2014 | 27454 | 0.090 |
Why?
|
Time | 1 | 2012 | 546 | 0.090 |
Why?
|
Post-Concussion Syndrome | 1 | 2013 | 256 | 0.090 |
Why?
|
Schools | 2 | 2023 | 1496 | 0.090 |
Why?
|
Cost-Benefit Analysis | 2 | 2019 | 5538 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 4039 | 0.090 |
Why?
|
Neurosurgical Procedures | 2 | 2019 | 2097 | 0.090 |
Why?
|
Esophageal Diseases | 1 | 2001 | 168 | 0.080 |
Why?
|
Pharyngeal Diseases | 1 | 2001 | 134 | 0.080 |
Why?
|
Patient Discharge | 3 | 2021 | 3476 | 0.080 |
Why?
|
Erythema | 1 | 2001 | 261 | 0.080 |
Why?
|
Catheter-Related Infections | 1 | 2012 | 275 | 0.080 |
Why?
|
Brazil | 1 | 2013 | 1248 | 0.080 |
Why?
|
Whooping Cough | 1 | 2010 | 86 | 0.080 |
Why?
|
Electronic Health Records | 4 | 2024 | 4875 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2013 | 499 | 0.080 |
Why?
|
Logistic Models | 6 | 2019 | 13323 | 0.080 |
Why?
|
Patient Care | 1 | 2014 | 629 | 0.080 |
Why?
|
Quality of Health Care | 3 | 2019 | 4339 | 0.080 |
Why?
|
Linear Models | 3 | 2017 | 5878 | 0.080 |
Why?
|
Haemophilus influenzae type b | 1 | 2008 | 16 | 0.080 |
Why?
|
Diptera | 1 | 2008 | 50 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1890 | 0.080 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 555 | 0.080 |
Why?
|
Meningitis, Meningococcal | 1 | 2008 | 43 | 0.080 |
Why?
|
Haemophilus Infections | 1 | 2008 | 94 | 0.080 |
Why?
|
Disease Reservoirs | 1 | 2008 | 123 | 0.080 |
Why?
|
Rest | 1 | 2013 | 951 | 0.070 |
Why?
|
Neisseria meningitidis | 1 | 2008 | 111 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2018 | 2181 | 0.070 |
Why?
|
Treatment Failure | 1 | 2014 | 2663 | 0.070 |
Why?
|
Bioterrorism | 1 | 2008 | 144 | 0.070 |
Why?
|
Laryngeal Diseases | 1 | 2001 | 248 | 0.070 |
Why?
|
Sodium Chloride | 2 | 2021 | 584 | 0.070 |
Why?
|
Radiation Injuries | 1 | 2015 | 1204 | 0.070 |
Why?
|
Hyperbilirubinemia | 1 | 2007 | 74 | 0.070 |
Why?
|
Immunoassay | 2 | 2024 | 745 | 0.070 |
Why?
|
Wounds and Injuries | 2 | 2017 | 2514 | 0.070 |
Why?
|
Zoonoses | 1 | 2008 | 180 | 0.070 |
Why?
|
Decision Making | 3 | 2014 | 3953 | 0.070 |
Why?
|
Massachusetts | 5 | 2015 | 8902 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2623 | 0.070 |
Why?
|
North America | 2 | 2021 | 1290 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2019 | 2185 | 0.070 |
Why?
|
Adult | 12 | 2024 | 223640 | 0.070 |
Why?
|
Rodentia | 1 | 2008 | 262 | 0.070 |
Why?
|
Cough | 1 | 2001 | 599 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2537 | 0.070 |
Why?
|
Health Resources | 1 | 2013 | 950 | 0.070 |
Why?
|
Odds Ratio | 5 | 2021 | 9682 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8051 | 0.070 |
Why?
|
Respiratory Sounds | 1 | 2001 | 702 | 0.070 |
Why?
|
Radiation Dosage | 1 | 2015 | 1974 | 0.070 |
Why?
|
Borrelia burgdorferi Group | 1 | 2006 | 96 | 0.070 |
Why?
|
RNA | 1 | 2016 | 2726 | 0.070 |
Why?
|
Coronary Artery Disease | 1 | 2006 | 6567 | 0.070 |
Why?
|
Injury Severity Score | 3 | 2017 | 1046 | 0.070 |
Why?
|
Anaphylaxis | 1 | 2013 | 758 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1742 | 0.060 |
Why?
|
Spinal Cord Injuries | 1 | 2013 | 929 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2021 | 65379 | 0.060 |
Why?
|
Consensus | 3 | 2020 | 3212 | 0.060 |
Why?
|
Leukocytes | 1 | 2014 | 2030 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2734 | 0.060 |
Why?
|
Latex Fixation Tests | 1 | 2004 | 29 | 0.060 |
Why?
|
Mid-Atlantic Region | 1 | 2024 | 24 | 0.060 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2011 | 1024 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8541 | 0.060 |
Why?
|
Prognosis | 6 | 2020 | 30022 | 0.060 |
Why?
|
Maryland | 1 | 2024 | 277 | 0.060 |
Why?
|
Intubation, Intratracheal | 1 | 2012 | 1359 | 0.060 |
Why?
|
Arthritis, Psoriatic | 1 | 2006 | 217 | 0.060 |
Why?
|
Headache | 1 | 2011 | 1262 | 0.050 |
Why?
|
Primary Health Care | 2 | 2017 | 4748 | 0.050 |
Why?
|
Mass Media | 1 | 2006 | 303 | 0.050 |
Why?
|
Platelet Count | 1 | 2006 | 784 | 0.050 |
Why?
|
Medical Records | 2 | 2019 | 1412 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4047 | 0.050 |
Why?
|
Canada | 2 | 2020 | 2139 | 0.050 |
Why?
|
Survival Analysis | 2 | 2012 | 10117 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2006 | 993 | 0.050 |
Why?
|
Athletic Injuries | 1 | 2013 | 1245 | 0.050 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1545 | 0.050 |
Why?
|
Streptococcus pneumoniae | 1 | 2008 | 764 | 0.050 |
Why?
|
Public Opinion | 1 | 2006 | 486 | 0.050 |
Why?
|
Blood Urea Nitrogen | 1 | 2022 | 187 | 0.050 |
Why?
|
Seasons | 1 | 2008 | 1526 | 0.050 |
Why?
|
Chronic Disease | 1 | 2017 | 9379 | 0.050 |
Why?
|
Internship and Residency | 2 | 2020 | 5949 | 0.050 |
Why?
|
Dehydration | 1 | 2023 | 216 | 0.050 |
Why?
|
Virginia | 1 | 2021 | 115 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1664 | 0.050 |
Why?
|
Insect Repellents | 1 | 2020 | 17 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13503 | 0.050 |
Why?
|
Romania | 1 | 2001 | 97 | 0.050 |
Why?
|
Scotland | 1 | 2001 | 142 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4859 | 0.040 |
Why?
|
Sepsis | 1 | 2014 | 2601 | 0.040 |
Why?
|
Animals | 5 | 2021 | 169337 | 0.040 |
Why?
|
Infectious Disease Medicine | 1 | 2020 | 49 | 0.040 |
Why?
|
Electrolytes | 1 | 2021 | 278 | 0.040 |
Why?
|
Drug Industry | 1 | 2006 | 793 | 0.040 |
Why?
|
Area Under Curve | 2 | 2017 | 1642 | 0.040 |
Why?
|
Communicable Diseases, Emerging | 1 | 2021 | 148 | 0.040 |
Why?
|
Oxazoles | 1 | 2001 | 199 | 0.040 |
Why?
|
Intelligence Tests | 1 | 2020 | 505 | 0.040 |
Why?
|
Atrioventricular Block | 1 | 2021 | 141 | 0.040 |
Why?
|
Spain | 1 | 2020 | 492 | 0.040 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 1133 | 0.040 |
Why?
|
Chlorides | 1 | 2021 | 663 | 0.040 |
Why?
|
Body Temperature | 1 | 2021 | 781 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 556 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2019 | 405 | 0.040 |
Why?
|
Middle Aged | 5 | 2024 | 223491 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3906 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2019 | 1379 | 0.030 |
Why?
|
Age Distribution | 2 | 2013 | 2877 | 0.030 |
Why?
|
Registries | 2 | 2011 | 8379 | 0.030 |
Why?
|
Exanthema | 1 | 2021 | 503 | 0.030 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2020 | 881 | 0.030 |
Why?
|
Population Surveillance | 1 | 2007 | 2598 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2024 | 2353 | 0.030 |
Why?
|
Escherichia coli | 1 | 2008 | 4211 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 2021 | 1150 | 0.030 |
Why?
|
Hospitals, University | 1 | 2017 | 569 | 0.030 |
Why?
|
Cost Savings | 1 | 2000 | 915 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2023 | 1218 | 0.030 |
Why?
|
Trust | 1 | 2019 | 532 | 0.030 |
Why?
|
Drug Utilization | 1 | 2020 | 1191 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2226 | 0.030 |
Why?
|
Health Literacy | 1 | 2019 | 468 | 0.030 |
Why?
|
Vaccination | 1 | 2006 | 3431 | 0.030 |
Why?
|
Law Enforcement | 1 | 2015 | 112 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3324 | 0.030 |
Why?
|
Proteins | 1 | 2008 | 6006 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1180 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 753 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2013 | 2728 | 0.030 |
Why?
|
RNA, Viral | 1 | 2002 | 2866 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 436 | 0.030 |
Why?
|
Ultrasonography | 1 | 2006 | 6001 | 0.030 |
Why?
|
Cost Control | 1 | 2015 | 627 | 0.030 |
Why?
|
Anxiety | 1 | 2007 | 4677 | 0.030 |
Why?
|
Overweight | 1 | 2023 | 2445 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2006 | 3231 | 0.020 |
Why?
|
Mental Disorders | 1 | 2012 | 6876 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2017 | 1195 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1389 | 0.020 |
Why?
|
Infant, Premature | 1 | 2021 | 2124 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1962 | 0.020 |
Why?
|
Program Development | 1 | 2017 | 1298 | 0.020 |
Why?
|
Accidents, Home | 1 | 2001 | 73 | 0.020 |
Why?
|
Health Care Costs | 2 | 2015 | 3267 | 0.020 |
Why?
|
Educational Measurement | 1 | 2018 | 1256 | 0.020 |
Why?
|
Memory | 1 | 2020 | 2210 | 0.020 |
Why?
|
Mentors | 1 | 2016 | 672 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4941 | 0.020 |
Why?
|
Product Labeling | 1 | 2001 | 76 | 0.020 |
Why?
|
Genetic Markers | 1 | 2016 | 2604 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 59686 | 0.020 |
Why?
|
Aged | 3 | 2024 | 171562 | 0.020 |
Why?
|
Accidents | 1 | 2010 | 164 | 0.020 |
Why?
|
Health Promotion | 1 | 2021 | 2209 | 0.020 |
Why?
|
Physicians | 2 | 2018 | 4614 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2281 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2001 | 357 | 0.020 |
Why?
|
Movement Disorders | 1 | 2012 | 464 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6409 | 0.020 |
Why?
|
Phenotype | 2 | 2021 | 16721 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1813 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2015 | 2437 | 0.020 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2001 | 417 | 0.020 |
Why?
|
Patient Readmission | 1 | 2021 | 3312 | 0.020 |
Why?
|
Device Removal | 1 | 2012 | 643 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8506 | 0.020 |
Why?
|
Video Recording | 1 | 2012 | 974 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2017 | 1946 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2012 | 783 | 0.020 |
Why?
|
Pregnancy | 1 | 2007 | 30200 | 0.020 |
Why?
|
Laryngoscopy | 1 | 2001 | 714 | 0.020 |
Why?
|
Computer Systems | 1 | 2007 | 470 | 0.020 |
Why?
|
Antibodies, Antinuclear | 1 | 2006 | 343 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1672 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5313 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3776 | 0.010 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2012 | 997 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7861 | 0.010 |
Why?
|
Dexamethasone | 1 | 2001 | 1965 | 0.010 |
Why?
|
Recovery of Function | 1 | 2013 | 2990 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8731 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9636 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5451 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6241 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1337 | 0.010 |
Why?
|
Cause of Death | 1 | 2012 | 3728 | 0.010 |
Why?
|
Reoperation | 1 | 2012 | 4341 | 0.010 |
Why?
|
Information Dissemination | 1 | 2010 | 1137 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2001 | 1813 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7145 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14784 | 0.010 |
Why?
|
Age of Onset | 1 | 2006 | 3345 | 0.010 |
Why?
|
Migraine Disorders | 1 | 2012 | 1713 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2001 | 8562 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 9063 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2012 | 5367 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12558 | 0.010 |
Why?
|
Epilepsy | 1 | 2012 | 3326 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13646 | 0.010 |
Why?
|